| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. (RNAC) has 13 insiders with recent SEC Form 4 filings, including 5 buys and 7 sells. RNAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.65M | $74.79M | - | |
| 10% | 511.6K | $4.43M | - | |
| CEO | 323.5K | $2.80M | - | |
| CFO | 121.2K | $1.05M | - | |
| Other | 94.2K | $815.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 | Kishimoto Takashi Kei73 | Chief Scientific Officer | Sell | 3,416 | $3.09 | $10,541.43 | -1.3% | -56.3% | -61.6% | |
| Jan 5, 2022 | Johnston Lloyd P.74 | Chief Operations Officer | Sell | 3,416 | $3.09 | $10,541.43 | -1.9% | -56.3% | -61.6% | |
| Jan 5, 2022 | Brunn Carsten86 | President And CEO | Sell | 13,597 | $3.09 | $41,958.98 | -2.6% | -56.3% | -61.6% | |
| Dec 15, 2021 | Springer Timothy A49 | Director, 10% Owner | Buy | 211,190 | $2.99 | $631,099.08 | +0.9% | -54.1% | -60.7% | |
| Dec 13, 2021 | Springer Timothy A49 | Director, 10% Owner | Buy | 3,821,273 | $3.06 | $11,687,810.04 | +5.9% | -52.4% | -56.3% | |
| Dec 10, 2021 | Brunn Carsten86 | President And CEO | Sell | 17,196 | $2.99 | $51,362.73 | -5.3% | -41.9% | -58.8% | |
| Dec 10, 2021 | Traber Peter G59 | Chief Medical Officer | Sell | 4,083 | $2.99 | $12,195.51 | -2.4% | -41.9% | -58.8% | |
| Dec 10, 2021 | Kishimoto Takashi Kei73 | Chief Scientific Officer | Sell | 4,370 | $2.99 | $13,052.75 | -2.1% | -41.9% | -58.8% | |
| Dec 10, 2021 | Johnston Lloyd P.74 | Chief Operations Officer | Sell | 4,370 | $2.99 | $13,052.75 | -3.9% | -41.9% | -58.8% | |
| Dec 3, 2021 | Cox Carrie Smith51 | Director | Buy | 17,200 | $2.95 | $50,664.32 | +26.2% | -40.1% | -54.0% |